Published in Gastrointest Endosc on May 27, 1992
Endoscopic evaluation of paraquat-induced upper gastrointestinal injury. Gastrointest Endosc (1993) 0.77
Spectrum of corrosive esophageal injury after intentional paraquat or glyphosate-surfactant herbicide ingestion. Int J Gen Med (2013) 0.77
Chronic ingestion of a potential food contaminant induces gastrointestinal inflammation in rats: role of nitric oxide and mast cells. Dig Dis Sci (2000) 0.75
A comparison of five maintenance therapies for reflux esophagitis. N Engl J Med (1995) 3.98
Gastric epithelial dysplasia in the natural history of gastric cancer: a multicenter prospective follow-up study. Interdisciplinary Group on Gastric Epithelial Dysplasia. Gastroenterology (1994) 3.15
Risk factors in community-acquired chronic hepatitis C virus infection: a case-control study in Italy. J Hepatol (1996) 2.19
Development of type 1 diabetes mellitus during interferon alfa therapy for chronic HCV hepatitis. Lancet (1992) 2.13
Gastroenterological oncology: a top priority. Dig Liver Dis (2000) 1.70
Histological features after liver transplantation in alcoholic cirrhotics. J Hepatol (2001) 1.69
How should patients with hepatocellular carcinoma be staged? Validation of a new prognostic system. Cancer (2000) 1.68
OLGA staging for gastritis: a tutorial. Dig Liver Dis (2008) 1.64
Chronic atrophic gastritis and Helicobacter pylori infection in primary biliary cirrhosis: a cross-sectional study with matching. Ital J Gastroenterol Hepatol (1997) 1.63
Incidence of secondary Helicobacter pylori resistance to antibiotics in treatment failures after 1-week proton pump inhibitor-based triple therapies: a prospective study. Dig Liver Dis (2000) 1.62
Early and advanced gastric cancer in the follow-up of moderate and severe gastric dysplasia patients. A prospective study. I.G.G.E.D.--Interdisciplinary Group on Gastric Epithelial Dysplasia. Endoscopy (1993) 1.58
Oxidative DNA damage accumulation in gastric carcinogenesis. Gut (1998) 1.57
Mitochondrial and other tissue antibodies in relatives of patients with primary biliary cirrhosis. Clin Exp Immunol (1972) 1.50
Digestive neuroendocrine tumours: diagnosis and treatment in Italy. A survey by the Oncology Study Section of the Italian Society of Gastroenterology (SIGE). Dig Liver Dis (2001) 1.50
Bovine lactoferrin for Helicobacter pylori eradication: an open, randomized, multicentre study. Aliment Pharmacol Ther (2006) 1.48
Autoimmune gastritis: histology phenotype and OLGA staging. Aliment Pharmacol Ther (2012) 1.48
Iron storage, lipid peroxidation and glutathione turnover in chronic anti-HCV positive hepatitis. J Hepatol (1995) 1.48
Association of keratin 8 gene mutation with chronic pancreatitis. Dig Liver Dis (2003) 1.46
Rate of incidence of hepatocellular carcinoma in patients with compensated viral cirrhosis. Cancer (1999) 1.43
The effect of Helicobacter pylori infection on NSAID-related gastroduodenal damage in the elderly. Eur J Gastroenterol Hepatol (1997) 1.42
Strategy for the retreatment of failed Helicobacter pylori eradication therapy: a case series. Ital J Gastroenterol Hepatol (1998) 1.40
Carbohydrate-induced thermogenesis in liver cirrhosis: glucose vs. fructose. Nutrition (1995) 1.39
Fasting hyperglycaemia following trans-catheter arterial chemo-embolization for hepatocellular carcinoma in cirrhosis. Ital J Gastroenterol Hepatol (1997) 1.39
Cure of Helicobacter pylori-positive active duodenal ulcer patients: a double-blind, multicentre, 12-month study comparing a two-week dual vs a one-week triple therapy. GISU (Interdisciplinary Group for Ulcer Study). Dig Liver Dis (2000) 1.39
Serum CA 19-9 and alpha-fetoprotein levels in primary hepatocellular carcinoma and liver cirrhosis. Cancer (1991) 1.39
Hormonal treatment of hepatocellular carcinoma. J Hepatol (1991) 1.38
The long term outcome of gastric non-invasive neoplasia. Gut (2003) 1.37
Hepatitis B virus infection in prisons. A seroepidemiological survey in prisoners and attending staff. J Hyg (Lond) (1982) 1.32
Immunological and histological studies in primary biliary cirrhosis. J Clin Pathol (1970) 1.29
Helicobacter pylori infection enhances mucosal interleukin-1 beta, interleukin-6, and the soluble receptor of interleukin-2. Int J Clin Lab Res (1996) 1.28
Association between reactive oxygen species and disease activity in chronic hepatitis C. Free Radic Biol Med (1996) 1.24
Helicobacter pylori virulence genes and host IL-1RN and IL-1beta genes interplay in favouring the development of peptic ulcer and intestinal metaplasia. Cytokine (2002) 1.20
Liver transplantation: the Italian experience. Dig Liver Dis (2002) 1.19
Analysis of Helicobacter pylori vacA and cagA genotypes and serum antibody profile in benign and malignant gastroduodenal diseases. Gut (1998) 1.14
Gastric epithelial dysplasia. How clinicopathologic background relates to management. Cancer (1995) 1.13
Prevalence of intestinal metaplasia in the distal oesophagus, oesophagogastric junction and gastric cardia in symptomatic patients in north-east Italy: a prospective, descriptive survey. The Italian Ulcer Study Group "GISU". Dig Liver Dis (2001) 1.11
Fas / FasL system, IL-1beta expression and apoptosis in chronic HBV and HCV liver disease. J Viral Hepat (2008) 1.11
Helicobacter pylori in promotion of gastric carcinogenesis. Dig Dis Sci (1996) 1.11
Squamous cell carcinoma antigen in human liver carcinogenesis. J Clin Pathol (2007) 1.10
Intermittent treatment with mesalazine in the prevention of diverticulitis recurrence: a randomised multicentre pilot double-blind placebo-controlled study of 24-month duration. Int J Colorectal Dis (2013) 1.10
Gastric epithelial dysplasia: a prospective multicenter follow-up study from the Interdisciplinary Group on Gastric Epithelial Dysplasia. Hum Pathol (1991) 1.10
Occurrence of Australia antigen in chronic hepatitis in Italy. Gastroenterology (1972) 1.09
Otilonium bromide in irritable bowel syndrome: a double-blind, placebo-controlled, 15-week study. Aliment Pharmacol Ther (1998) 1.08
Clinical usefulness of serum pepsinogens I and II, gastrin-17 and anti-Helicobacterpylori antibodies in the management of dyspeptic patients in primary care. Dig Liver Dis (2005) 1.07
[Is there a role for double-contrast radiology in the characterization of patients with non-ulcer dyspepsia?]. Radiol Med (1991) 1.07
The Italian experience on paediatric liver transplantation: 1988-1999 report. Dig Liver Dis (2002) 1.06
Discrepancies between reported food intolerance and sensitization test findings in irritable bowel syndrome patients. Am J Gastroenterol (1999) 1.05
Fine-needle biopsy in focal liver lesions: the usefulness of a screening programme and the role of cytology and microhistology. Ital J Gastroenterol (1995) 1.04
Helicobacter pylori serology in patients with chronic gastritis. Am J Gastroenterol (1996) 1.04
Pathology of the gastric antrum and body associated with Helicobacter pylori infection in non-ulcerous patients: is the bacterium a promoter of intestinal metaplasia? Histopathology (1993) 1.03
Follow-up in gastric dysplasia patients. Am J Surg Pathol (1989) 1.03
The role of cysteine and serine proteases in colorectal carcinoma. Cancer (1999) 1.03
Prevalence of Helicobacter pylori resistance to antibiotics in Northeast Italy: a multicentre study. GISU. Interdisciplinary Group for the Study of Ulcer. Dig Liver Dis (2000) 1.03
Intention-to-treat analysis of liver transplantation in selected, aggressively treated HCC patients exceeding the Milan criteria. Am J Transplant (2007) 1.03
Hepatitis C virus: from oxygen free radicals to hepatocellular carcinoma. J Viral Hepat (2007) 1.02
Gastric antioxidant, nitrites, and mucosal lipoperoxidation in chronic gastritis and Helicobacter pylori infection. J Clin Gastroenterol (1996) 1.01
The effect of antibiotic resistance on the outcome of three 1-week triple therapies against Helicobacter pylori. Aliment Pharmacol Ther (1999) 1.00
Oxidative DNA damage in circulating leukocytes occurs as an early event in chronic HCV infection. Free Radic Biol Med (1999) 0.99
Bone metabolism in orthotopic liver transplantation: a prospective study. Liver Transpl Surg (1998) 0.99
Unresectable hepatocellular carcinoma in cirrhosis: survival, prognostic factors, and unexpected side effects after transcatheter arterial chemoembolization. Dig Dis Sci (1996) 0.98
Atrophic gastritis: pathology and endoscopy in the reversibility assessment. Gut (2003) 0.98
Extended lymphadenectomy (D2) in patients with early gastric cancer. Eur J Surg Oncol (2005) 0.97
Hepatocyte proliferative activity in chronic liver damage as assessed by the monoclonal antibody MIB1 Ki67 in archival material: the role of etiology, disease activity, iron, and lipid peroxidation. Hepatology (1996) 0.97
What do patients want to know about their inflammatory bowel disease? Ital J Gastroenterol (1993) 0.97
Unresectable hepatocellular carcinoma: a prospective controlled trial with tamoxifen. J Hepatol (1990) 0.96
Cytokine, infiltrating macrophage and T cell-mediated response to development of primary and secondary human liver cancer. Dig Liver Dis (2002) 0.95
Hepatitis B virus infection in Cameroon: a seroepidemiological survey in city school children. J Med Virol (1991) 0.95
Altered esophageal pain threshold in irritable bowel syndrome. Dig Dis Sci (1993) 0.95
DNA oxidative damage in leukocytes correlates with the severity of HCV-related liver disease: validation in an open population study. J Hepatol (2001) 0.95
Is tissue polypeptide antigen more accurate than serum CEA for diagnosing pancreatic cancer? J Clin Pathol (1986) 0.95
Gastric cell c-AMP stimulating autoantibodies in duodenal ulcer disease. Gut (1988) 0.95
Conscious sedation during endoscopic retrograde colangiopancreatography: implementation of SIED-SIAARTI-ANOTE guidelines in Belluno Hospital. Minerva Anestesiol (2005) 0.94
Proteases in gastrointestinal neoplastic diseases. Clin Chim Acta (2000) 0.93
The impact of liver disease and medical complications on quality of life and psychological distress before and after liver transplantation. J Hepatol (2000) 0.93
Tissue polypeptide antigen (TPA) in pancreatic cancer diagnosis. Br J Cancer (1985) 0.93